Samsung Biologics Statistics

Total Valuation

KRX:207940 has a market cap or net worth of KRW 76.01 trillion. The enterprise value is 76.17 trillion.

Market Cap	76.01T
Enterprise Value	76.17T

Important Dates

The next estimated earnings date is Wednesday, April 23, 2025.

Earnings Date	Apr 23, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:207940 has 71.17 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	71.17M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	14.11%
Float	18.07M

Valuation Ratios

The trailing PE ratio is 70.17 and the forward PE ratio is 60.11.

PE Ratio	70.17
Forward PE	60.11
PS Ratio	16.72
PB Ratio	6.97
P/TBV Ratio	9.58
P/FCF Ratio	213.71
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 39.63, with an EV/FCF ratio of 214.15.

EV / Earnings	70.31
EV / Sales	16.75
EV / EBITDA	39.63
EV / EBIT	57.59
EV / FCF	214.15

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.14.

Current Ratio	1.43
Quick Ratio	0.35
Debt / Equity	0.14
Debt / EBITDA	0.77
Debt / FCF	4.18
Interest Coverage	26.37

Financial Efficiency

Return on equity (ROE) is 10.45% and return on invested capital (ROIC) is 6.84%.

Return on Equity (ROE)	10.45%
Return on Assets (ROA)	4.94%
Return on Invested Capital (ROIC)	6.84%
Return on Capital Employed (ROCE)	9.79%
Revenue Per Employee	958.54M
Profits Per Employee	228.35M
Employee Count	4,744
Asset Turnover	0.27
Inventory Turnover	0.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.76% in the last 52 weeks. The beta is 0.34, so KRX:207940's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	+29.76%
50-Day Moving Average	1,070.00
200-Day Moving Average	952,300.00
Relative Strength Index (RSI)	42.78
Average Volume (20 Days)	65,811

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:207940 had revenue of KRW 4.55 trillion and earned 1.08 trillion in profits. Earnings per share was 15,220.67.

Revenue	4.55T
Gross Profit	2.27T
Operating Income	1.32T
Pretax Income	1.37T
Net Income	1.08T
EBITDA	1.92T
EBIT	1.32T
Earnings Per Share (EPS)	15,220.67

Full Income Statement

Balance Sheet

The company has 1.33 trillion in cash and 1.49 trillion in debt, giving a net cash position of -154.95 billion or -2,177.07 per share.

Cash & Cash Equivalents	1.33T
Total Debt	1.49T
Net Cash	-154.95B
Net Cash Per Share	-2,177.07
Equity (Book Value)	10.90T
Book Value Per Share	153,211.51
Working Capital	1.66T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.66 trillion and capital expenditures -1,303.57 billion, giving a free cash flow of 355.68 billion.

Operating Cash Flow	1.66T
Capital Expenditures	-1,303.57B
Free Cash Flow	355.68B
FCF Per Share	4,997.36

Full Cash Flow Statement

Margins

Gross margin is 50.01%, with operating and profit margins of 29.03% and 23.82%.

Gross Margin	50.01%
Operating Margin	29.03%
Pretax Margin	30.13%
Profit Margin	23.82%
EBITDA Margin	42.20%
EBIT Margin	29.03%
FCF Margin	7.82%

Dividends & Yields

KRX:207940 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.43%
FCF Yield	0.47%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:207940 has an Altman Z-Score of 6.83.

Altman Z-Score	6.83
Piotroski F-Score	n/a